Nicolan (Nicorandil)

Nicorandil works through a dual mechanism. It releases nitric oxide, which activates guanylate cyclase and raises cyclic GMP levels, causing smooth‑muscle relaxation and vasodilation. Simultaneously, it opens ATP‑sensitive potassium channels in vascular smooth muscle, leading to hyperpolarisation and further arterial dilation. The combined effect reduces preload and afterload, decreasing myocardial oxygen demand.

The dosage of Nicolan is individualized. A prescriber determines the appropriate strength, frequency, and duration based on the patient’s clinical condition, response, and tolerance. Patients should follow the prescribing information provided by their healthcare professional and not adjust the dose without medical advice.

The safety of nicorandil during pregnancy and lactation has not been established. Because the pregnancy category is unknown, the drug should be avoided unless the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should also consult their physician before using Nicolan.

To request Nicolan, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nicolan (nicorandil) differs from traditional nitrates and beta‑blockers by combining nitrate‑like nitric‑oxide donation with potassium‑channel activation. This dual action can provide more balanced vasodilation and may be useful when patients experience tolerance to pure nitrates. Compared with ranolazine, nicorandil has a more pronounced effect on preload reduction, while ranolazine primarily improves myocardial metabolism.

Nicolan tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments to maintain potency.

Nicolan is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether to split or crush tablets. Consistent daily intake helps maintain stable plasma levels and optimal anti‑anginal effect.

The most serious risks include severe hypotension, which can cause dizziness, fainting, or shock; tachycardia or other arrhythmias; rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome; and gastrointestinal ulceration or perforation. Patients should seek immediate medical attention if they experience sudden weakness, chest pain, unusual skin rash, or severe abdominal discomfort.

Nicolan is contraindicated in patients with severe hypotension, recent myocardial infarction, uncontrolled heart failure, or known hypersensitivity to nicorandil or any nitrate. Caution is also advised for individuals with significant liver disease, and it should be avoided during pregnancy and lactation unless clearly indicated by a physician.